New VDA 4: 2020, English version 2021 is avilable here.

 

PRICES include / exclude VAT
Homepage>BS Standards>11 HEALTH CARE TECHNOLOGY>11.040 Medical equipment>11.040.40 Implants for surgery, prosthetics and orthotics>21/30390833 DC BS EN ISO 21535. Non-active surgical implants. Joint replacement implants. Specific requirements for hip-joint replacement implants
Sponsored link
immediate downloadReleased: 2021-07-22
21/30390833 DC BS EN ISO 21535. Non-active surgical implants. Joint replacement implants. Specific requirements for hip-joint replacement implants

21/30390833 DC

BS EN ISO 21535. Non-active surgical implants. Joint replacement implants. Specific requirements for hip-joint replacement implants

Format
Availability
Price and Currency
English Secure PDF
Immediate download
25.88 USD
English Hardcopy
In stock
25.88 USD
Standard number:21/30390833 DC
Pages:36
Released:2021-07-22
Status:Draft for Comment
DESCRIPTION

21/30390833 DC


This standard 21/30390833 DC BS EN ISO 21535. Non-active surgical implants. Joint replacement implants. Specific requirements for hip-joint replacement implants is classified in these ICS categories:
  • 11.040.40 Implants for surgery, prosthetics and orthotics

This document provides specific requirements for hip joint replacement implants. With regard to safety, this document specifies requirements for intended performance, design attributes, materials, design evaluation, manufacture, sterilization, packaging, information supplied by the manufacturer, and methods of test.

This document applies to both total and partial hip joint replacement implants. It applies to components made of metallic and non-metallic materials.

This document applies to a wide variety of hip replacement implants, but for some specific hip replacement implant types, some considerations, not specifically covered in this document, may be applicable. Further details are given in Clause 7.2.1.1.

The requirements which are specified in this document are not intended to require the re-design or re-testing of devices which have been legally marketed and for which there is a history of sufficient and safe clinical use. For such devices compliance with this document shall be demonstrated by providing evidence of the sufficient and safe clinical use.


This product includes: